NCT04340440View on ClinicalTrials.gov

Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

February 29, 2020

Conditions
Gastric Cancer
Interventions
PROCEDURE

D1 lymphadenectomy

Radical gastrectomy with D1 lymphadenectomy

PROCEDURE

D2 lymphadenectomy

Radical gastrectomy with D2 lymphadenectomy

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT04340440 - Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma | Biotech Hunter | Biotech Hunter